Neuland Laboratories Current Share Price | Neuland Laboratories Stock Screener
NEULANDLAB
Pharmaceuticals
Neuland Laboratories Current Stock Price Today
Live Share Price NSE
₹22840.00
▲
175.00 (0.77%)
Live Share Price BSE
₹22875.70
▲
219.50 (0.97%)
As of September 18, 2026, the live Neuland Laboratories share price (NSE: NEULANDLAB) is ₹22,840.00 on NSE and ₹22,875.70 on BSE, up 0.77% from the previous close, with shares trading between ₹22,440.00 and ₹23,030.00 in today's trading session, and a 52-week range of ₹11,555.00–₹23,995.00.
Browse NEULANDLAB cash flow statement to support your investment research.
Use the Neuland Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Neuland Laboratories Market Cap
₹30,195.14 Cr.
NEULANDLAB P/E Ratio (TTM)
61.35
Neuland Laboratories P/B Ratio
16.30
EPS (TTM)
₹283.71
Dividend Yield
0.14%
Debt to Equity
0.13
NEULANDLAB 52 Week High
₹23995.00
Neuland Laboratories 52 Week Low
₹11555.00
Operating Margin
40.00%
Profit Margin
27.00%
NEULANDLAB Revenue (TTM)
₹789.00
EBITDA
₹320.00
Net Income
₹213.00
Total Assets
₹2,930.00
Total Equity
₹1,875.00
Neuland Laboratories Current Share Price Chart
Track the current Neuland Laboratories share price and stock price with an interactive chart. Analyse NEULANDLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Neuland Laboratories stock quote in one place.
Neuland Laboratories Company Profile - Fundamental Screener
Screen Neuland Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NEULANDLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE794A01010
Neuland Laboratories Balance Sheet Screener
Screen NEULANDLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,930 | 2,180 | 1,833 | 1,580 | 1,384 | 1,325 | 1,231 | 1,130 | 1,071 | 886 |
| Current Assets | 1,483 | 1,140 | 921 | 761 | 581 | 550 | 515 | 454 | 447 | 375 |
| Fixed Assets | 1,177 | 955 | 824 | 758 | 767 | 716 | 653 | 542 | 475 | 466 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 346 | 189 | 122 | 147 | 180 | 170 | 163 | 104 | 146 | 54 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,875 | 1,525 | 1,283 | 994 | 841 | 787 | 710 | 699 | 558 | 546 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 9 | 9 |
| Reserves & Surplus | 1,862 | 1,512 | 1,270 | 981 | 828 | 774 | 697 | 686 | 549 | 537 |
Neuland Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Neuland Laboratories income statement and profit fundamentals.
Analyze NEULANDLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Neuland Laboratories share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 789 | 650 | 336 | 301 | 516 | 448 | 390 | 465 | 315 | 458 | 415 | 365 | 421 | 395 | 257 |
| Expenses | 469 | 419 | 277 | 258 | 359 | 363 | 278 | 316 | 249 | 311 | 287 | 266 | 280 | 272 | 217 |
| EBITDA | 320 | 231 | 59 | 42 | 157 | 85 | 112 | 149 | 67 | 146 | 128 | 99 | 141 | 123 | 40 |
| Operating Profit % | 40.00% | 35.00% | 16.00% | 12.00% | 30.00% | 18.00% | 28.00% | 28.00% | 20.00% | 22.00% | 29.00% | 27.00% | 33.00% | 31.00% | 15.00% |
| Depreciation | 25 | 27 | 17 | 20 | 23 | 24 | 17 | 16 | 16 | 16 | 14 | 14 | 15 | 15 | 12 |
| Interest | 7 | 7 | 2 | 5 | 5 | 7 | 4 | 3 | 1 | 2 | 4 | 2 | 4 | 4 | 3 |
| Profit Before Tax | 288 | 198 | 39 | 18 | 129 | 55 | 92 | 130 | 49 | 128 | 110 | 83 | 122 | 105 | 24 |
| Tax | 75 | 50 | 12 | 4 | 33 | 14 | 25 | 32 | 17 | 26 | 26 | 21 | 32 | 23 | 3 |
| Net Profit | 213 | 148 | 28 | 14 | 97 | 41 | 68 | 98 | 33 | 102 | 85 | 62 | 89 | 81 | 22 |
| EPS | 165.76 | 115.10 | 21.67 | 10.83 | 75.49 | 31.62 | 52.66 | 76.28 | 25.60 | 79.18 | 65.90 | 48.23 | 69.56 | 63.44 | 16.97 |
Neuland Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen NEULANDLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 347 | 317 | 261 | 237 | 60 | 189 | 57 | 70 | 11 | 39 |
| Investing Activities | -423 | -298 | -150 | -61 | -95 | -85 | -49 | -77 | -116 | -42 |
| Financing Activities | 21 | 25 | -69 | -136 | 38 | -114 | -6 | 12 | 105 | 0 |
| Net Cash Flow | -55 | 44 | 42 | 40 | 3 | -9 | 3 | 5 | 0 | -4 |
Neuland Laboratories Shareholding Pattern Screener
See Neuland Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Neuland Laboratories promoter holding and ownership changes for NEULANDLAB on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.63% | 32.62% | 32.68% | 32.68% | 32.64% | 32.63% | 32.74% | 32.72% |
| FII Holding | 20.46% | 21.08% | 22.11% | 21.69% | 20.60% | 20.90% | 24.44% | 25.72% |
| DII Holding | 15.84% | 16.51% | 10.97% | 11.57% | 13.54% | 14.71% | 6.54% | 6.39% |
| Govt Holding | 0.00% | 0.00% | 0.40% | 0.40% | 0.40% | 0.00% | 0.40% | 0.40% |
| Public Holding | 23.84% | 22.88% | 25.86% | 25.55% | 24.72% | 24.31% | 27.97% | 27.05% |
| Other Holding | 7.22% | 6.91% | 7.99% | 8.12% | 8.09% | 7.45% | 7.91% | 7.71% |
| Shareholder Count | 46,304 | 44,340 | 39,333 | 42,419 | 44,393 | 46,187 | 28,616 | 29,077 |
Neuland Laboratories Share Dividend Screener - Share Yield Analysis
Check Neuland Laboratories dividend history with payout and yield data.
View Neuland Laboratories dividend details including ex-dates and amounts for NEULANDLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹34.00 | 0.14% |
| 2025-March | ₹12.00 | 0.10% |
| 2024-March | ₹14.00 | 0.12% |
| 2023-March | ₹10.00 | 0.16% |
| 2022-March | ₹5.00 | 0.28% |
| 2021-March | ₹5.00 | 0.49% |
| 2020-March | ₹2.00 | 0.10% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Neuland Laboratories Stock Index Membership
See which indices include Neuland Laboratories stock.
Check NEULANDLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMLCAP 100
NIFTY SMLCAP 250
NIFTY SMLCAP 50
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Neuland Laboratories Market Events Screener - Corporate Actions
Get Neuland Laboratories corporate actions including splits, bonuses, and buybacks.
Check Neuland Laboratories stock events that may affect NEULANDLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-05 | 2026-08-05 | Quarterly Result Announcement | NA | 4.70% |
| 2026-08-04 | 2026-08-04 | Annual General Meeting | NA | 12.11% |
| 2026-07-24 | 2026-07-24 | Dividend | ₹ 34.00 /share | 5.00% |
| 2026-05-12 | 2026-05-12 | Quarterly Result Announcement | NA | 14.69% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -4.05% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | 8.38% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 13.07% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | 11.04% |
| 2025-07-18 | 2025-07-18 | Dividend | ₹ 12.00 /share | 16.23% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | -2.72% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.73% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -2.42% |
| 2024-07-31 | 2024-07-31 | Annual General Meeting | NA | 26.65% |
| 2024-07-12 | 2024-07-13 | Dividend | ₹ 14.00 /share | 13.26% |
| 2023-07-11 | 2023-07-12 | Dividend | ₹ 10.00 /share | 41.77% |
Neuland Laboratories Competitors Screener - Peer Comparison
Screen NEULANDLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Neuland Laboratories Company Announcements - News Screener
Screen NEULANDLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-14 | Disclosure Under Regulation 30 Of SEBI Listing Regulations | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-08-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-14 | Intimation Regarding Completion Of US FDA Inspection | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-05 | Disclosure Under Regulation 30 Of SEBI Listing Regulations | - |
| 2026-08-05 | Disclosure Under Regulation 30 Of SEBI Listing Regulations | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-05 | Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-08-05 | Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-08-04 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-04 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-31 | Intimation Under Regulation 30 Of SEBI Listing Regulations | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |